LFST Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
435.4M
+7.9%
403.5M
+5.6%
382.2M
+5.1%
363.8M
+5.4%
345.3M
Cost of Revenue
282.3M
+5.5%
267.5M
+4.6%
255.9M
+3.5%
247.2M
+4.4%
236.9M
Gross Profit
153.0M
+12.6%
135.9M
+7.6%
126.3M
+8.3%
116.6M
+7.5%
108.4M
Operating Expenses
122.8M
+7.4%
114.4M
+5.6%
108.3M
-0.8%
109.2M
-2.0%
111.4M
R&D
SG&A
108.1M
+7.8%
100.3M
+5.9%
94.8M
-0.9%
95.6M
-1.8%
97.4M
Operating Income
30.2M
+40.1%
21.6M
+20.0%
18.0M
+142.4%
7.4M
+351.2%
-2950000
EBITDA
44.5M
+27.5%
34.9M
+11.1%
31.4M
+49.7%
21.0M
+89.6%
11.1M
Net Income
23.6M
+65.8%
14.2M
+22.1%
11.7M
+983.4%
1.1M
+128.4%
-3791000
EPS (Basic)
$0.06
+50.0%
$0.04
+0.0%
$0.04
$-0.01
EPS (Diluted)
$0.06
+50.0%
$0.04
+33.3%
$0.03
$-0.01
Shares (Diluted)
387.3M
-2.0%
395.1M
+1.0%
391.1M
+0.6%
388.9M
+0.6%
386.7M
LifeStance Health (LFST) — Financials